title: A progress report on the outpatient treatment of patients with advanced renal cell carcinoma using subcutaneous recombinant interleukin-2.
authors.affiliation: Department of Medical Oncology, University Hospital, Groningen, The Netherlands.
authors.forename: J
authors.initials: J
authors.lastname: Buter
authors.forename: D T
authors.initials: DT
authors.lastname: Sleijfer
authors.forename: W T
authors.initials: WT
authors.lastname: van der Graaf
authors.forename: E G
authors.initials: EG
authors.lastname: de Vries
authors.forename: P H
authors.initials: PH
authors.lastname: Willemse
authors.forename: N H
authors.initials: NH
authors.lastname: Mulder
mesh_terms: D000328:Adult; D000368:Aged; D000553:Ambulatory Care; D002292:Carcinoma, Renal Cell / Q000556:secondary / Q000628:therapy*; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D007376:Interleukin-2 / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D012646:Self Administration; D016019:Survival Analysis
chemical_list: D007376:Interleukin-2; D011994:Recombinant Proteins; C082598:aldesleukin